Tekturna HCT is a prescription medicine licensed to treat high blood pressure. This selection from the eMedTV Web site offers an overview of the drug, including information on how it works, dosing guidelines, possible side effects, and more.
Dizziness, diarrhea, and coughing are among the most common side effects reported with Tekturna HCT. This eMedTV segment also takes an in-depth look at some of the more serious Tekturna HCT side effects, such as seizures and unexplained swelling.
If you are taking Tekturna HCT (aliskiren-HCTZ), coughing may be a potential side effect of the medicine. This eMedTV page discusses the possible link between Tekturna HCT and a cough, explaining how often the side effect occurred in clinical trials.
Tekturna HCT is prescribed to help lower high blood pressure in adults. This eMedTV article explores how the two medications in Tekturna HCT work to relax the blood vessels and reduce blood volume. There are currently no off-label Tekturna HCT uses.
This eMedTV resource explains that the recommended Tekturna HCT dosage for treating high blood pressure will vary, depending on several factors. This page describes the factors that may affect your dose and also offers tips on taking Tekturna HCT.
This portion of the eMedTV archives explores potential Tekturna HCT drug interactions with other medications, such as ACE inhibitors, potassium products, and ARBs. This Web page also explains how these interactions can cause serious complications.
You should not take Tekturna HCT if you have certain allergies or if you are not producing any urine. This eMedTV page takes an in-depth look at a number of Tekturna HCT warnings and precautions, including a list of who should not take this drug.
It is possible to take too much Tekturna HCT (aliskiren-HCTZ). This portion of the eMedTV Web site describes Tekturna HCT overdose symptoms, such as dehydration, kidney failure, and an electrolyte imbalance. This page also covers treatment options.
Tekturna HCT (aliskiren-HCTZ) can cause serious problems to a fetus if it is used during pregnancy. This eMedTV resource describes some of the possible complications associated with Tekturna HCT and pregnancy, such as kidney problems and fetal death.
Some components in Tekturna HCT (aliskiren-HCTZ) pass through breast milk and may cause problems. This eMedTV page takes a look at Tekturna HCT and breastfeeding, and explains why the manufacturer advises that breastfeeding women not use the drug.
This eMedTV page explains that there is no generic Tekturna HCT (aliskiren-HCTZ) product available at this time. This page explains when a generic version of the drug might become available and covers why aliskiren-HCTZ is not a generic Tekturna HCT.
